Key Takeaways
- Policy shock absorbed, margins rescued the quarter: Revenue fell to ₹828 cr (down 9% YoY) as the sugar-syrup ethanol ban froze order finalizations, but PBT and PAT rose 7% and 13% respectively on a richer sales mix and softer input costs.
- The 3X growth target is reaffirmed, not revised: Management stated it has “absolutely no reason to believe that we will not meet or beat” the target, pointing to the Global Biofuel Alliance, SAF, CBG, and bioplastics as the drivers.
- Multi-feedstock pivot is the immediate fix for 1G ethanol: Praj is converting single-feedstock plants to handle grain and bagasse, a shift that began only a month ago and will take 4–6 months for customer dialogues to mature into orders.
- SAF and CBG pipelines are building but still pre-revenue: Six SAF engineering studies are underway ahead of US 45Z clarity, while CBG orders are flowing from a five-project LOI; both segments need policy or commissioning milestones to convert.
- What to watch next quarter: Whether multi-feedstock conversion dialogues turn into orders, the IOCL 2G plant commissioning in Q1 FY25, and the pace of margin improvement as site activity returns in Q4.
The Sugar-Syrup Shock and the Multi-Feedstock Answer
- What broke: The government’s ban on using sugar syrup for ethanol, later revised to a 0.17 crore metric ton diversion cap, stopped all order finalizations for sugar-based ethanol plants in Q3 as customers and their bankers reassessed project viability.
- What didn’t break: Existing contracts were not cancelled, only shifted in their execution cycle; the ₹250 cr of pure syrup projects are delayed, not lost.
- The fix Praj is selling: Customers are being offered conversion of single-feedstock plants to multi-feedstock, connecting starchy modules and adding bagasse-based ethanol capability, creating input flexibility against future policy swings.
- Early traction: Praj already has commercial-scale dual-feed plants running for some sugar customers, and enquiries for conversion have begun, though management declined to quantify the mix in the order book.
- The timeline risk: Management described this as “literally a month old phenomena” and expects 4–6 months for customer dialogues to develop, meaning revenue conversion is a FY25 story.
Shishir Joshipura: “This is very new, this is just literally a month old phenomena that has happened.”
Margin Performance: The Quarter’s Real Story
- The headline paradox: Revenue contracted but profitability expanded, with PBT up 7% and PAT up 13% YoY, driven by a richer mix of exports, engineering and services orders, softening material costs, and a drop in one-time other expenses.
- Site activity was a temporary tailwind: Lower site activity, a lower-margin business, flattered margins this quarter; management cautioned it may increase in Q4, implying the reported margin level may not repeat immediately.
- The commitment, with a caveat: Management confirmed margins will continue to develop positively, but “the quantum of change may vary” and “not necessarily in the same proportion” as this quarter.
- Export share provides structural support: Exports accounted for 21% of Q3 revenue, and the growing international order book, including the first US low-carbon ethanol order and high-capacity fermenter exports, shifts the mix toward higher-margin business.
Shishir Joshipura: “It may move it may have different quantum's of change, but all the quantum will be on the positive side that is our confirmation and commitment.”
The 3X Growth Bet: Policy Tailwinds, Not Just Orders
- The target stands: Management expressed full confidence in meeting or beating the 3X revenue growth target set earlier, citing government policy momentum in bioenergy, SAF, CBG, bioplastics, and bio-manufacturing.
- Global Biofuel Alliance as a pipeline: The GBA now has 22 member countries and 12 international organizations; Praj has initiated dialogue with 10 member countries to help develop their bioenergy programs, creating a policy-driven export funnel.
- Energy transition as the growth engine: Management expects the energy transition business to become a “very, very significant component of our business numbers as we move forward,” with fermentation technology benefiting bioenergy, renewable chemicals and materials, and PHS.
- The IOCL JV catalyst: Both Boards have approved the JV, the agreement structure is finalized, and approval from Niti Aayog and DIPAM is awaited; management is already working on the sidelines to develop a product pipeline, but cannot disclose details until formal approval.
Shishir Joshipura: “We have absolutely no reason to believe that we will not meet or beat our target that we set out of 3X growth.”
SAF and CBG: The Pre-Revenue Engines
Sustainable Aviation Fuel
- Demo plant inaugurated: A fully integrated Alcohol-to-Jet demonstration facility, described as first-of-its-kind, was inaugurated at Praj Matrix in January 2024 by the Oil Minister.
- Six engineering projects underway: Customers are completing feasibility and engineering work now so that projects can start without delay when the US section 45Z Inflation Reduction Act clarification arrives, expected before June 2024.
- The conversion trigger: 45Z clarity could convert engineering contracts into equipment supply orders in H2 FY25; India is positioned as a preferred SAF production destination, with more detail promised over the next 12 months.
Compressed Biogas
- Orders flowing from the LOI: Four more orders were received as part of the five-project LOI with one conglomerate, and a healthy enquiry pipeline is developing.
- HPCL plant inaugurated, stabilization underway: A CBG plant for HPCL in UP was inaugurated by the Oil Minister; production takes a 90-day cycle to stabilize due to bacterial degradation of biomass.
- The 1% mandate creates runway: The CBO program mandates 1% blending from FY26, rising to 5% from FY29, giving projects a 12–15 month commissioning window with policy backing.
- Market share ambition is clear, quantification is not: Management declared “no intention to be anything but the leader,” but declined to estimate market share, calling it too early.
Shishir Joshipura: “We are right now working on several engineering projects so customer said okay let's get the engineering part done let's get the feasibility report done. So that when this notification is come as expected, then we can start the project and don't lose the time right now.”
2G Ethanol: The Showcase Project and Its Delays
- IOCL Panipat delayed: The plant has been pushed from its original target due to feedstock supply chain challenges; there is no established supply chain for rice straw, which farmers previously burned.
- The novelty defense: Management argued this is a worldwide challenge for first-of-kind 2G projects, with multiple dimensions: who harvests, at what cost, who puts up capital, land, storage, and supply.
- The catalyst: Recommissioning is underway in a two-stage program with IOCL, with plant performance to be established in Q1 FY25; this will serve as a showcase for European 2G ethanol interest, where active dialogue has resumed after a slowdown.
- The pushback: An analyst questioned why feedstock issues weren’t foreseen when the project was awarded five years ago; management did not directly answer, instead reiterating the complexity of building a supply chain from scratch.
Shishir Joshipura: “This is a experience worldwide it's not only in India. So, the feedstock challenge is clearly understood because there are different dimensions to it as to who harvest the feedstock, at what cost, who puts the capital, who puts the land, who stores it, who supplies it, there are different dimensions to this.”
New Facilities and the Bio-Manufacturing Option
- GenX facility, Mangalore: All statutory compliances completed; commercial production expected by mid-February; enquiries for energy transition needs are building well.
- PLA bio-plastic demo plant: Installation nearing completion; operations expected to start by April 2024, ahead of any bio-manufacturing policy details.
- Bio-manufacturing policy unknown: Management acknowledged the government’s bio-manufacturing announcement but said no policy details are available yet; Praj is betting its pilot project commissioning in Q1 FY25 positions it ahead of the curve.
- Distributor network being built: Praj is establishing a strong distributor network in chosen markets for enzymes, yeast, and performance enhancers, a downstream move that complements its technology positioning.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| 3X revenue growth target | Meet or beat the previously set 3X growth target | No end-date stated; FY30 implied by earlier target context |
| IOCL 2G plant performance | Establish plant performance in two-stage program with IOCL | Q1 FY25 |
| PLA demo plant operations | Commission and demonstrate bio-plastic pilot project | April 2024 / Q1 FY25 |
| GenX facility commercial production | Begin commercial production at Mangalore | Mid-February 2024 |
| Multi-feedstock dialogue development | Customer dialogues for feedstock diversification to mature | Next 4–6 months |
| SAF engineering-to-equipment conversion | 45Z clarity to convert engineering contracts to equipment supply | H2 FY25, contingent on US 45Z clarification before June 2024 |
| IOCL JV approval | Niti Aayog and DIPAM approval for formal JV announcement | No date; approval process underway |
| Margin trajectory | Continued positive development, quantum may vary | Ongoing; Q4 site activity may moderate the pace |
Key Metrics
| Metric | Q3 FY24 |
|---|---|
| Consolidated income from operations | ₹828 cr, compared to ₹911 cr in Q3 FY23 |
| PBT | ₹91.9 cr, up 7% YoY from ₹85.9 cr in Q3 FY23 |
| PAT | ₹70.4 cr, compared to ₹62.3 cr in Q3 FY23 |
| 9M FY24 income from operations | ₹2,440 cr, compared to ₹2,520 cr in 9M FY23 |
| 9M FY24 PBT | ₹250 cr, compared to ₹210 cr in 9M FY23 |
| 9M FY24 PAT | ₹190 cr, compared to ₹150 cr in 9M FY23 |
| Export revenue share | 21% of Q3 FY24 revenue |
| Revenue mix | 71% Bio-energy, 21% engineering, 8% PHS |
| Order intake | ₹1,030 cr, 86% domestic, 81% Bio-Energy, 12% engineering, 7% PHS |
| Order backlog | ₹3,950 cr as of September 2023, 75% domestic |
| Cash in hand | ₹640 cr as of September 30, 2023 |
| CBG order book (syrup-based plants) | ₹250 cr, execution delayed |
| B-Heavy order book | ₹450 cr, includes C molasses feedstock capability |
| PHS order book | Crossed entire FY23 order book in 9M FY24 |
| SAF engineering projects underway | 6 projects in the United States |